Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bcworldpharm CoXKRX:200780 +1.00%66 PB Ratio is 0.45 as of Sep. 13, 2026, which is 60% below its 10-year median of 1.13. GuruFocus rates XKRX:200780 with a GF Score™ of 66/100 and a GF Value™ of ₩5,477.85 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 926 Drug Manufacturers companies, Bcworldpharm Co ranks better than 93.41% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-09-13), Bcworldpharm Co's share price is ₩3040.00. Bcworldpharm Co's Book Value per Share for the quarter that ended in Jun. 2026 was ₩6,803.27. Hence, Bcworldpharm Co's PB Ratio of today is 0.45.
Good Sign:
Bcworldpharm Co Ltd stock PB Ratio (=0.45) is close to 10-year low of 0.44.
The historical rank and industry rank for Bcworldpharm Co's PB Ratio or its related term are showing as below:
XKRX:200780'
s PB Ratio Range Over the Past 10 Years
Min: 0.44 Med: 1.13 Max: 2.87
Current: 0.45
During the past 13 years, Bcworldpharm Co's highest PB Ratio was 2.87. The lowest was 0.44. And the median was 1.13.
XKRX:200780's PB Ratio is ranked better than 93.41% of 926
companies
in the Drug Manufacturers industry
Industry Median: 1.95
vs XKRX:200780: 0.45
During the past 12 months, Bcworldpharm Co's average Book Value Per Share Growth Rate was -5.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -3.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -1.70% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -0.10% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Bcworldpharm Co was 46.40% per year. The lowest was -5.70% per year. And the median was 0.50% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Bcworldpharm Co PB Ratio Related Terms
Bcworldpharm Co PB Ratio Historical Data
* Premium members only.
The historical data trend for Bcworldpharm Co's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKRX:200780 vs LLY, JNJ, ABBV: PB Ratio Comparison
For the Drug Manufacturers - General subindustry, Bcworldpharm Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bcworldpharm Co PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bcworldpharm Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Bcworldpharm Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Bcworldpharm Co's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Bcworldpharm Co (XKRX:200780) has a PB Ratio of 0.45 as of Sep. 13, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Bcworldpharm Co and its competitors. This is 60% below median its historical median of 1.13. Over the past decade, Bcworldpharm Co's PB Ratio has ranged from 0.44 to 2.87. According to the industry distribution chart, Bcworldpharm Co ranks #61 out of 926 companies in the Drug Manufacturers industry, placing it in the top 6.6%.
Is Bcworldpharm Co's PB Ratio too high?
Bcworldpharm Co's current PB Ratio of 0.45 is 60% below median its 10-year median of 1.13. Over the past 10 years, this metric has ranged from a low of 0.44 to a high of 2.87. The Drug Manufacturers industry median PB Ratio is 1.95. Bcworldpharm Co's value of 0.45 is 76.9% below this industry median. Based on the distribution chart, Bcworldpharm Co ranks #61 out of 926 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Bcworldpharm Co has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bcworldpharm Co's PB Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Bcworldpharm Co ranks #61 out of 926 companies for PB Ratio. This places Bcworldpharm Co in the top 7% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.95. Bcworldpharm Co's value of 0.45 is 76.9% below this benchmark. Historically, Bcworldpharm Co's own PB Ratio has ranged from 0.44 to 2.87 over the past decade. While the company's 10-year median is 1.13 vs. the industry median of 1.95, Bcworldpharm Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.95, based on 926 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bcworldpharm Co's current PB Ratio of 0.45 is 76.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Bcworldpharm Co and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bcworldpharm Co's current PB Ratio is 0.45, which is 60% below median its own 10-year median of 1.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bcworldpharm Co stock overvalued right now?
Based on GuruFocus' analysis, Bcworldpharm Co (XKRX:200780) is currently considered Possible Value Trap. The stock's GF Value™ is ₩5,477.85, compared to a current price of ₩3,040.00 — trading 44.5% below its estimated fair value. The current PB Ratio is 0.45, which is 60% below median its 10-year median of 1.13 and 76.9% below the Drug Manufacturers industry median of 1.95. Bcworldpharm Co's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Bcworldpharm Co (XKRX:200780), the current PB Ratio is 0.45 as of Sep. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bcworldpharm Co (XKRX:200780) Overvalued in 2026?
Based on GuruFocus' analysis, Bcworldpharm Co stock appears to be undervalued.
The current stock price of ₩3,040.00 is trading 44.5% below its estimated GF Value™ of ₩5,477.85.
GuruFocus considers Bcworldpharm Co to be Possible Value Trap.
Key valuation signals for XKRX:200780:
PB Ratio: 0.45 (60% below median its 10-year median of 1.13)
GF Value™: ₩5,477.85 vs. price of ₩3,040.00 (44.5% below fair value)
Industry Position: 76.9% below the Drug Manufacturers median (#61 of 926)
No single metric tells the full story. See the XKRX:200780 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bcworldpharm Co Ltd is a pharmaceutical company. The company is engaged in research and develop new and improved drugs through R&D and technological innovation. The Company's products include Anti-TB, Anti-Diabetic, Analgesics, Narcotics Antidotes and Hemostatics.
66GF Score
Get the complete analysis for XKRX:200780
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:200780 has been successfully added to your 
